Jin Medical International Ltd. (Jin Med)

Jin Medical International Ltd. is a Cayman Islands-incorporated holding company that operates primarily through its subsidiaries in China, focusing on the design, development, and manufacturing of rehabilitation medical equipment. Headquartered in Changzhou City, Jiangsu Province, China, the company's mission centers on providing essential living aids for individuals with disabilities, the elderly, and those recovering from injuries.

The company's core business revolves around a diverse range of wheelchairs, including both manual and electric models, along with various wheelchair components. Beyond mobility devices, Jin Medical International also offers a broader product ecosystem that includes oxygen concentrators, bath aids, rehabilitative devices, oxygen chambers, beauty instruments, shampoo instruments, and nano thermal therapy chambers. Its products are distributed across Mainland China, Japan (a significant revenue source), the United States, Hong Kong, Singapore, Korea, and Australia.

Under the leadership of Chairman and CEO Erqi Wang, Jin Medical International has recently expanded its manufacturing capabilities, launching production at its new Chuzhou facility (Plant No. 3) in July 2025, which is projected to produce 200,000 units of mid-to-high-end electric wheelchairs and senior mobility scooters annually. The company also regained compliance with Nasdaq's minimum bid price requirement in April 2026, following a 1-for-20 share combination in March 2026. Additionally, Jin Medical International has diversified its offerings by expanding into lifestyle beauty products.